Mail-Meds Clinical Pharmacy First to Use ALRT's Constant Health Companion(TM) ("CHC(TM)") to Address the $150 Billion Healthcare Problem

Richmond, Virginia, UNITED STATES

WINSTON-SALEM, NC--(Marketwire - November 26, 2007) - ALR Technologies, Inc. (OTCBB: ALRT) is pleased to announce that Mail-Meds Clinical Pharmacy ("Mail-Meds") is starting a disease management program to provide the CHC™ system to qualified Medicare and Medicaid patients. Mail-Meds, based in Ft. Myers, FL, also provides medication adherence pharmacy services through the use of its Med-Box™ Personalized Pill Box System. Mail-Meds contracts with Medicare/Medicaid focused clinics that treat people with diabetes, heart disease, HIV/AIDS and mental health conditions.

Mail-Meds, currently serving thousands of patients in Florida, is looking to expand into other major metropolitan areas including New Orleans, Atlanta, Washington, D.C., Houston, Dallas and Baltimore.

The CHC is a portable and easy to use adherence monitoring system. It addresses treatment non-adherence by patients with chronic illnesses. The system enhances efficiency of healthcare providers and facilitates timely intervention of non-adherent patients. Non-adherence of treatments currently contributes to over $150 billion a year of preventable excess healthcare costs. ALRT's CHC system provides the only comprehensive and affordable solution to this $150 billion a year problem.

Mail-Meds will be providing the CHC system at no extra charge to qualified patients. There are approximately 40 million Medicare patients and 46 million Medicaid patients in the United States. With baby boomers reaching retirement age, the Medicare population is expected to increase by nearly 50% over the next five years.

"We are pleased to offer this service to qualified patients," reports Mark J. Theobald, President and CEO of Mail-Meds, "where medication adherence is critical to maintaining their health. The combination of the CHC and the Mail-Meds Med-Box™ will address the major issues driving non-adherence. Our mission is to be the industry leader in improving medication adherence for chronically ill patients. Our total service package will improve health outcomes for these patients and reduce the escalating healthcare costs."

About Mail-Meds Clinical Pharmacy

Mail-Meds Clinical Pharmacy specializes in simplifying medication regimens and improving medication adherence for chronic illness patients that take multiple medications. Through the use of its medication adherence tools, adherence training, and specialty pharmacy services, patients are empowered to manage their difficult medication regimens while improving their health and quality of life. Established in 2004, Mail-Meds Clinical Pharmacy operates successful medication adherence programs with specialty clinics that manage diabetes, heart failure, HIV/AIDS and mental health patients. In addition, Mail-Meds Clinical Pharmacy provides medication adherence services and programs to support managed care plans, disease management initiatives, assisted living facilities and group homes. More information about Mail-Meds can be found at:, or by calling them toll free at 800-939-2022.

About ALR Technologies, Inc.

ALR Technologies, Inc. (ALRT) designs and manufactures health management compliance products and monitoring and intervention systems. ALRT's primary system, Constant Health Companion™, fills a serious gap in standard disease management practices. It provides for continued and affordable compliance supervision of patients after they have left the direct care of professionals. More information on ALR Technologies and its products can be found at More information about the Constant Health Companion can be found at:

This release contains certain "forward-looking statements" relating to ALR Technologies' business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words "estimate," "expect," "anticipate," "believe" and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the company's quarterly filings with the Securities Exchange Commission.

Contact Information: Contact: ALR Technologies, Inc. Public Relations 336-722-2254